On Friday, the European Banking Authority (EBA) published the results of the 2018 stress tests, which showed that all the participating banks had satisfactory liquidity to fend off a 2008-like financial crisis. However, contrary to what market experts had expected, British banks Barclays and Lloyds scored lowest among the 48 banks that underwent the test.
A common tier ratio of 5.5% was regarded as the threshold of a liquidity crisis. Anything below that meant the firm had to unload some of its risky assets in order to maintain shareholder confidence. Barclays scored the lowest, with a common tier ratio of 6.37%, followed by Lloyds with a score of 6.8%. According to EBA, the low scores are primarily attributable to their wide credit exposure.
Italian banks were expected to fare poorly in the test, given the recent economic crisis and the decrease in government bond valuation, but they still fared better than Barclays. The worst performer from Italy was Banco BPM, with a score of 6.67%, followed by UBI Banca, with a common tier ratio of 7.42%. The largest lender of the country, Unicredit, registered 9.34%.
Meanwhile, Frankfort-headquartered Deutsche Bank performed relatively better with a score of 8.14%. The central bank of the United Kingdom, The Bank of England, will announce its own stress test results in December, the financial institution said on Friday.
Director of Economic Analysis and Statistics at the EBA, Mario Quagliariello, said, “The outcome of the stress test shows that banks’ efforts to build up their capital base in the recent years have contributed to strengthening their resilience and capacity to withstand the severe shocks and material capital impacts of the 2018 exercise. The results will be used by supervisors as part of their wider assessment of banks’ vulnerabilities and input to their supervisory decisions”.
Earlier in June, US-based banking giants had cleared stress tests conducted by the Federal Reserve. It may be noted that US banks are currently ahead of their European counterparts in terms of loan quality, profitability and cost discipline.
Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on